Hubbry Logo
logo
Menstruation avatar
Menstruation
Community hub

Menstruation

logo
0 subscribers
Read side by side
Menstruation
View on Wikipedia
from Wikipedia

Diagram illustrating how the uterine lining builds up and breaks down during the menstrual cycle

Menstruation (also known as a period, among other colloquial terms) is the regular discharge of blood and mucosal tissue from the inner lining of the uterus through the vagina.[1] The menstrual cycle is characterized by the rise and fall of hormones.[1] Menstruation is triggered by falling progesterone levels, and is a sign that pregnancy has not occurred.[1] Feminine hygiene products are used in order to maintain hygiene during menses.

The first period, a point in time known as menarche, usually begins during puberty, between the ages of 11 and 13.[2] However, menstruation starting as young as eight years would still be considered normal.[3] The average age of the first period is generally later in the developing world, and earlier in the developed world.[4] The typical length of time between the first day of one period and the first day of the next is 21 to 45 days in young women; in adults, the range is between 21 and 35 days with the average often cited as 28 days.[3][4] In the largest study of menstrual app data, the mean menstrual cycle length was determined to be 29.3 days.[5] Bleeding typically lasts two to seven days. Periods stop during pregnancy and typically do not resume during the initial months of breastfeeding.[3] Lochia occurs after childbirth.[6] Menstruation, and with it the possibility of pregnancy, ceases after menopause, which usually occurs between 45 and 55 years of age.[7]

During their menstrual period, 38% of all women reported not to be able to perform all their regular daily activities[8]. Symptoms in advance of menstruation that do interfere with normal life are called premenstrual syndrome (PMS). Some 20 to 30% of women experience PMS, with 3 to 8% experiencing severe symptoms.[9] These include acne, tender breasts, bloating, feeling tired, irritability, and mood changes.[10] Other symptoms some women experience include painful periods (estimates are between 50 and 90%) and heavy bleeding during menstruation and abnormal bleeding at any time during the menstrual cycle.[3] A lack of periods, known as amenorrhea, is when periods do not occur by age 15 or have not re-occurred in ninety days.[3]

Characteristics

[edit]
Further information: Menstrual cycle

Length and duration

[edit]

The first menstrual period occurs after the onset of pubertal growth, and is called menarche. The average age of menarche is 12 to 15 years.[2][11] However, it may occur as early as eight.[3] The average age of the first period is generally later in the developing world, and earlier in the developed world.[4][12] The average age of menarche has changed little in the United States since the 1950s.[4]

Menstruation is the most visible phase of the menstrual cycle and its beginning is used as the marker between cycles. The first day of menstrual bleeding is the date used for the last menstrual period (LMP). The typical length of time between the first day of one period and the first day of the next is 21 to 45 days in young women, and 21 to 35 days in adults.[3][4] The average menstrual cycle length is conventionally said to be 28 days.[3][4] In the largest study using data from menstrual apps, the mean menstrual cycle length was determined as 29.3 days.[5] The variability of menstrual cycle lengths is highest for women under 25 years of age and is lowest, that is, most regular, for ages 25 to 39 years.[13] The variability increases slightly for women aged 40 to 44 years.[13]

Perimenopause refers to the transitional phase leading up to menopause, marked by hormonal changes and irregular menstrual cycles, when a woman stops menstruating completely and is no longer fertile. The medical definition of menopause is one year without a period and typically occurs between 45 and 55 years in Western countries.[7][14]: 381  Menopause before age 45 is considered premature in industrialized countries.[15] Illnesses, certain surgeries, or medical treatments may cause menopause to occur earlier than it might have otherwise.[16]

Menstrual fluid

[edit]
Menstrual cup filled with menstrual fluid

The average volume of menstrual fluid during a monthly menstrual period is 35 ml (1.2 US fl oz) with 10–80 ml (0.34–2.71 US fl oz) considered typical. Menstrual fluid is the correct term for the flow, although many people prefer to refer to it as "menstrual blood". Menstrual fluid is reddish-brown, a slightly darker color than venous blood.[14]: 381 

About half of menstrual fluid is blood. This blood contains sodium, calcium, phosphate, iron, and chloride, the extent of which depends on the woman. As well as blood, the fluid consists of cervical mucus, vaginal secretions, and endometrial tissue. Vaginal fluids in menses mainly contribute water, common electrolytes, organ moieties, and at least 14 proteins, including glycoproteins.[17]

Many women and girls notice blood clots during menstruation. These appear as clumps of blood that may look like tissue. If there was a miscarriage or a stillbirth, examination under a microscope can confirm if it was endometrial tissue or pregnancy tissue (products of conception) that was shed.[18] Sometimes menstrual clots or shed endometrial tissue is incorrectly thought to indicate an early-term miscarriage of an embryo. An enzyme called plasmin – contained in the endometrium – tends to inhibit the blood from clotting.[19]

The amount of iron lost in menstrual fluid is relatively small for most women.[better source needed][20] In one study, premenopausal women who exhibited symptoms of iron deficiency were given endoscopies. 86% of them actually had gastrointestinal disease and were at risk of being misdiagnosed simply because they were menstruating.[non-primary source needed][21] Heavy menstrual bleeding, occurring monthly, can result in anemia.[22]

Hormonal changes

[edit]
This section is an excerpt from Menstrual cycle.[edit]

The menstrual cycle is a series of natural changes in hormone production and the structures of the uterus and ovaries of the female reproductive system that makes pregnancy possible. The ovarian cycle controls the production and release of eggs and the cyclic release of estrogen and progesterone. The uterine cycle governs the preparation and maintenance of the lining of the uterus (womb) to receive an embryo. These cycles are concurrent and coordinated, normally last between 21 and 35 days, with a median length of 28 days. Menarche (the onset of the first period) usually occurs around the age of 12 years; menstrual cycles continue for about 30–45 years.

Naturally occurring hormones drive the cycles; the cyclical rise and fall of the follicle stimulating hormone prompts the production and growth of oocytes (immature egg cells). The hormone estrogen stimulates the uterus lining (endometrium) to thicken to accommodate an embryo should fertilization occur. The blood supply of the thickened lining provides nutrients to a successfully implanted embryo. If implantation does not occur, the lining breaks down and blood is released. Triggered by falling progesterone levels, menstruation (commonly referred to as a "period") is the cyclical shedding of the lining, and is a sign that pregnancy has not occurred.

Side effects

[edit]

Menstrual health overview

[edit]
This section is an excerpt from Menstrual cycle § Menstrual health.[edit]
A human primary ovarian follicle viewed by microscopy. The round oocyte stained red in the center is surrounded by a layer of granulosa cells, which are enveloped by the basement membrane and theca cells. The magnification is around 1000 times. (H&E stain)

Although a normal and natural process,[23] some women experience premenstrual syndrome with symptoms that may include acne, tender breasts, and tiredness.[24] More severe symptoms that affect daily living are classed as premenstrual dysphoric disorder and are experienced by 3 to 8% of women.[25][26][24][27] Dysmenorrhea (menstrual cramps or period pain) is felt as painful cramps in the abdomen that can spread to the back and upper thighs during the first few days of menstruation.[28][29][30] Debilitating period pain is not normal and can be a sign of something severe such as endometriosis.[31] These issues can significantly affect a woman's health and quality of life and timely interventions can improve the lives of these women.[32]

There are common culturally communicated misbeliefs that the menstrual cycle affects women's moods, causes depression or irritability, or that menstruation is a painful, shameful or unclean experience. Often a woman's normal mood variation is falsely attributed to the menstrual cycle. Much of the research is weak, but there appears to be a very small increase in mood fluctuations during the luteal and menstrual phases, and a corresponding decrease during the rest of the cycle.[33] Changing levels of estrogen and progesterone across the menstrual cycle exert systemic effects on aspects of physiology including the brain, metabolism, and musculoskeletal system. The result can be subtle physiological and observable changes to women's athletic performance including strength, aerobic, and anaerobic performance.[34]

Moods and premenstrual syndrome (PMS)

[edit]
Main article: Menstruation and mental health
This section is an excerpt from Premenstrual syndrome.[edit]

Premenstrual syndrome (PMS) is a disruptive set of emotional and physical symptoms that regularly occur in the one to two weeks before the start of each menstrual period.[35][36] Symptoms resolve around the time menstrual bleeding begins.[35] Symptoms vary,[37] though commonly include one or more physical, emotional, or behavioral symptoms, that resolve with menses.[38] The range of symptoms is wide, and most commonly are breast tenderness, bloating, headache, mood swings, depression, anxiety, anger, and irritability. To be diagnosed as PMS, rather than a normal discomfort of the menstrual cycle, these symptoms must interfere with daily living, during two menstrual cycles of prospective recording.[38] PMS-related symptoms are often present for about six days.[39] An individual's pattern of symptoms may change over time.[39] PMS does not produce symptoms during pregnancy or following menopause.[40]

Diagnosis requires a consistent pattern of emotional and physical symptoms occurring after ovulation and before menstruation to a degree that interferes with normal life.[41] Emotional symptoms must not be present during the initial part of the menstrual cycle.[41] A daily list of symptoms over a few months may help in diagnosis.[39] Other disorders that cause similar symptoms need to be excluded before a diagnosis is made.[39]

The cause of PMS is unknown, but the underlying mechanism is believed to involve changes in hormone levels during the course of the whole menstrual cycle.[40] Reducing salt, alcohol, caffeine, and stress, along with increasing exercise is typically all that is recommended for the management of mild symptoms.[40] Calcium and vitamin D supplementation may be useful in some.[39] Anti-inflammatory drugs such as ibuprofen or naproxen may help with physical symptoms.[40] In those with more significant symptoms, birth control pills or the diuretic spironolactone may be useful.[40][39]

Over 90% of women report having some premenstrual symptoms, such as bloating, headaches, and moodiness.[37] Premenstrual symptoms generally do not cause substantial disruption, and only qualify as PMS in approximately 20% of pre-menopausal women.[35] Antidepressants of the selective serotonin reuptake inhibitors (SSRI) class may be used to treat the emotional symptoms of PMS.[35]

Premenstrual dysphoric disorder (PMDD) is a more severe condition that has greater psychological symptoms.[39][40] PMDD affects about 3% of women of child-bearing age.[35]

Cramps

[edit]

In most women, various physical changes are brought about by fluctuations in hormone levels during the menstrual cycle. This includes muscle contractions of the uterus (menstrual cramping) that can precede or accompany menstruation. Many women experience painful cramps, also known as dysmenorrhea, during menstruation.[42] Among adult women, 2%–28% have pain severe enough to affect daily activity.[42] Severe symptoms that disrupt daily activities and functioning may be diagnosed as premenstrual dysphoric disorder.[43] These symptoms can be severe enough to affect a person's performance at work, school, and in everyday activities in a small percentage of women.[9]

When severe pelvic pain and bleeding suddenly occur or worsen during a cycle, this could be due to ectopic pregnancy and spontaneous abortion. This is checked by using a pregnancy test, ideally as soon as unusual pain begins, because ectopic pregnancies can be life‑threatening.[44]

The most common treatment for menstrual cramps are non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs can be used to reduce moderate to severe pain, and all appear similar.[45] About 1 in 5 women do not respond to NSAIDs and require alternative therapy, such as simple analgesics or heat pads.[46] Other medications for pain management include aspirin or paracetamol and combined oral contraceptives. Although combined oral contraceptives may be used, there is insufficient evidence for the efficacy of intrauterine progestogens.[45]

One review found tentative evidence that acupuncture may be useful, at least in the short term.[47] Another review found insufficient evidence to determine an effect.[48]

Interactions with other conditions

[edit]

Known interactions between the menstrual cycle and certain health conditions include:

  • Some women with neurological conditions experience increased activity of their conditions at about the same time during each menstrual cycle. For example, drops in estrogen levels may trigger migraines,[medical citation needed] [49] especially when the woman who has migraines is also taking the birth control pill.
  • Many women with epilepsy have more seizures in a pattern linked to the menstrual cycle; this is called "catamenial epilepsy".[50] Different patterns seem to exist (such as seizures coinciding with the time of menstruation, or coinciding with the time of ovulation), and the frequency with which they occur has not been firmly established.
  • Research indicates that women have a significantly higher likelihood of anterior cruciate ligament injuries in the pre-ovulatory stage, than post-ovulatory stage.[51]

Sexual activity

[edit]
Further information: Culture and menstruation

Sexual feelings and behaviors change during the menstrual cycle. Before and during ovulation, high levels of estrogen and androgens result in women having a relatively increased interest in sexual activity, and relatively lower interest directly prior to and during menstruation.[52] Unlike other mammals, women may show interest in sexual activity across all days of the menstrual cycle, regardless of fertility.[53]

There is no reliable scientific evidence that would advise against sexual intercourse during menstruation based on medical grounds.[medical citation needed]

Fertility aspects

[edit]

Peak fertility (the time with the highest likelihood of pregnancy resulting from sexual intercourse) occurs during just a few days of the cycle: usually two days before and two days after the ovulation date.[54] This corresponds to the second and the beginning of the third week in a 28-day cycle. This fertile window varies from woman to woman, just as the ovulation date often varies from cycle to cycle for the same woman.[55] A variety of methods have been developed to help individual women estimate the relatively fertile and the relatively infertile days in the cycle; these systems are called fertility awareness.[medical citation needed]

Menstrual disorders

[edit]
Main article: Menstrual disorder

Infrequent or irregular ovulation is called oligoovulation.[56] The absence of ovulation is called anovulation. Normal menstrual flow can occur without ovulation preceding it: an anovulatory cycle. In some cycles, follicular development may start but not be completed; nevertheless, estrogens will be formed and stimulate the uterine lining. Anovulatory flow resulting from a very thick endometrium caused by prolonged, continued high estrogen levels is called estrogen breakthrough bleeding. Anovulatory bleeding triggered by a sudden drop in estrogen levels is called withdrawal bleeding.[57] Anovulatory cycles commonly occur before menopause (perimenopause) and in women with polycystic ovary syndrome.[58]

Very little flow (less than 10 ml) is called hypomenorrhea. Regular cycles with intervals of 21 days or fewer are polymenorrhea; frequent but irregular menstruation is known as metrorrhagia. Sudden heavy flows or amounts greater than 80 ml are termed menorrhagia.[59] Heavy menstruation that occurs frequently and irregularly is menometrorrhagia. The term for cycles with intervals exceeding 35 days is oligomenorrhea.[60] Amenorrhea refers to more than three[59] to six[60] months without menses (while not being pregnant) during a woman's reproductive years. The term for painful periods is dysmenorrhea.

There is a wide spectrum of differences in how women experience menstruation. There are several ways that someone's menstrual cycle can differ from the norm:

Term Meaning
Oligomenorrhea Infrequent periods
Hypomenorrhea Short or light periods
Polymenorrhea Frequent periods (more frequently than every 21 days)
Hypermenorrhea Heavy or long periods (soaking a sanitary napkin or tampon every hour, menstruating longer than 7 days)
Dysmenorrhea Painful periods
Intermenstrual bleeding Breakthrough bleeding (also called spotting)
Amenorrhea Absent periods

Extreme psychological stress can also result in periods stopping.[61] More severe symptoms of anxiety or depression may be signs of premenstrual dysphoric disorder (PMDD) which is a depressive disorder.[62]

Dysfunctional uterine bleeding is a hormonally caused bleeding abnormality. Dysfunctional uterine bleeding typically occurs in premenopausal women who do not ovulate normally (i.e. are anovulatory). All these bleeding abnormalities need medical attention; they may indicate hormone imbalances, uterine fibroids, or other problems. As pregnant women may bleed, a pregnancy test forms part of the evaluation of abnormal bleeding.[medical citation needed]

Women who had undergone female genital mutilation (particularly type III- infibulation) a practice common in parts of Africa, may experience menstrual problems, such as slow and painful menstruation, that is caused by the near-complete sealing off of the vagina.[63]

Dysmenorrhea

[edit]
This section is an excerpt from Dysmenorrhea.[edit]
Menstrual cycle and changes in hormone production

Dysmenorrhea, also known as period pain, painful periods or menstrual cramps, is pain during menstruation.[64][65][66] Its usual onset occurs around the time that menstruation begins.[67] Symptoms typically last less than three days.[67] The pain is usually in the pelvis or lower abdomen.[67] Other symptoms may include back pain, diarrhea or nausea.[67]

Dysmenorrhea can occur without an underlying problem.[68][69] Underlying issues that can cause dysmenorrhea include uterine fibroids, adenomyosis, and most commonly, endometriosis.[68] It is more common among those with heavy periods, irregular periods, those whose periods started before twelve years of age and those who have a low body weight.[67] A pelvic exam and ultrasound in individuals who are sexually active may be useful for diagnosis.[67] Conditions that should be ruled out include ectopic pregnancy, pelvic inflammatory disease, interstitial cystitis and chronic pelvic pain.[67]

Dysmenorrhea occurs less often in those who exercise regularly and those who have children early in life.[67][70] Treatment may include the use of a heating pad.[68] Medications that may help include NSAIDs such as ibuprofen, hormonal birth control and the IUD with progestogen.[67][68] Taking vitamin B1 or magnesium may help.[66] Evidence for yoga, acupuncture and massage is insufficient.[67] Surgery may be useful if certain underlying problems are present.[66]

Estimates of the percentage of female adolescents and women of reproductive age affected are between 50% and 90%,[64][69] and the Women's Health Concern estimates it to be around 80%.[71] It is the most common menstrual disorder.[66] Typically, it starts within a year of the first menstrual period.[67] When there is no underlying cause, often the pain improves with age or following having a child.[66]

Menstrual hygiene management

[edit]
Main articles: Menstrual hygiene management and Feminine hygiene
Disposable sanitary napkin
Disposable sanitary napkin
Tampon in plastic applicator
The elements of a tampon with applicator. Left: the bigger tube ("penetrator"). Center: cotton tampon with attached string. Right: the narrower tube.
Menstrual cup
Menstrual cup
Cloth menstrual pad
Cloth menstrual pad

Menstrual products (also called "feminine hygiene" products) are made to absorb or catch menstrual blood. A number of different products are available – some are disposable, some are reusable. Where women can afford it, items used to absorb or catch menses are usually commercially manufactured products. Menstruating women manage menstruation primarily by wearing menstrual products such as tampons, napkins or menstrual cups to catch the menstrual blood.

The main disposable products (commercially manufactured) include:

  • Sanitary napkins (also called sanitary towels or pads) – Rectangular pieces of material worn attached to the underwear to absorb menstrual flow, often with an adhesive backing to hold the pad in place. Disposable pads may contain wood pulp or gel products, usually with a plastic lining and bleached.
  • Tampons – Disposable cylinders of treated rayon/cotton blends or all-cotton fleece, usually bleached, that are inserted into the vagina to absorb menstrual flow.

The main reusable products include:

Due to poverty, some women cannot afford commercial feminine hygiene products.[72][73] Instead, they use materials found in the environment or other improvised materials.[74][75] "Period poverty" is a global issue affecting women and girls who do not have access to safe, hygienic sanitary products.[76] In addition, solid waste disposal systems in developing countries are often lacking, which means women have no proper place to dispose used products, such as pads.[77] Inappropriate disposal of used materials also creates pressures on sanitation systems as menstrual hygiene products can create blockages of toilets, pipes and sewers.[72] In the UK research has shown that for women who are allotment growers, access to sanitation for menstrual hygiene management is limited.[78]

Menstrual suppression

[edit]
Main article: Menstrual suppression

Due to hormonal contraception

[edit]
Main article: Hormonal contraception
Half-used blister pack of a combined oral contraceptive. The white pills are placebos, mainly for the purpose of reminding the woman to continue taking the pills.

Menstruation can be delayed by the use of progesterone or progestins. For this purpose, oral administration of progesterone or progestin during cycle day 20 has been found to effectively delay menstruation for at least 20 days, with menstruation starting after 2–3 days have passed since discontinuing the regimen.[79]

Hormonal contraception affects the frequency, duration, severity, volume, and regularity of menstruation and menstrual symptoms. The most common form of hormonal contraception is the combined birth control pill, which contains both estrogen and progestogen. Although the primary function of the pill is to prevent pregnancy, it may be used to improve some menstrual symptoms and syndromes which affect menstruation, such as polycystic ovary syndrome (PCOS), endometriosis, adenomyosis, amenorrhea, menstrual cramps, menstrual migraines, menorrhagia (excessive menstrual bleeding), menstruation-related or fibroid-related anemia and dysmenorrhea (painful menstruation) by creating regularity in menstrual cycles and reducing overall menstrual flow.[80][81]

Using the combined birth control pill, it is also possible for a woman to delay or eliminate menstrual periods, a practice called menstrual suppression.[82] Some women do this simply for convenience in the short-term,[83] while others prefer to eliminate periods altogether when possible. This can be done either by skipping the placebo pills, or using an extended cycle combined oral contraceptive pill, which were first marketed in the U.S. in the early 2000s. This continuous administration of active pills without the placebo can lead to the achievement of amenorrhea in 80% of users within 1 year of use.[84]

Due to breastfeeding

[edit]
Main article: Lactational amenorrhea

Breastfeeding causes negative feedback to occur on pulse secretion of gonadotropin-releasing hormone (GnRH) and luteinizing hormone (LH).[85] Depending on the strength of the negative feedback, breastfeeding women may experience complete suppression of follicular development, follicular development but no ovulation, or normal menstrual cycles may resume.[86] Suppression of ovulation is more likely when suckling occurs more frequently.[87] The production of prolactin in response to suckling is important to maintaining lactational amenorrhea.[88] On average, women who are fully breastfeeding whose infants suckle frequently experience a return of menstruation at fourteen and a half months postpartum. There is a wide range of response among individual breastfeeding women, however, with some experiencing return of menstruation at two months and others remaining amenorrheic for up to 42 months postpartum.[89]

Society and culture

[edit]
Main article: Culture and menstruation
Amra Padatik India, celebration of Menstrual Hygiene Day in India

Etymology and terminology

[edit]

The word menstruation is etymologically related to moon. The terms menstruation and menses are derived from the Latin mensis 'month', which in turn relates to the ancient Greek mene 'moon' and to the roots of the English words month and moon.[90]

Some organizations have begun to use the term "menstruator" instead of "menstruating women", a term that has been in use since at least 2010.[91] Menstruator is used by activists and scholars in order to "express solidarity with women who do not menstruate, transgender men who do, and intersexual and genderqueer individuals".[91]: 950  The term can be contentious between different schools of feminist thought; however, the argument is made that since gender identities are lived, the reality is that people of different genders menstruate.[91]: 950  The term "people who menstruate" is also used.[92]

Traditions, taboos and education

[edit]
See also: Menstruation in Islam, Woman prayer, and Istihadha

Many religions have menstruation-related traditions, for example: Islam prohibits sexual contact with women during menstruation in the 2nd chapter of the Quran.[93] Some scholars argue that menstruating women are in a state in which they are unable to maintain wudhu, and are therefore prohibited from touching the Arabic version of the Qur'an.[94] In Judaism, a woman during menstruation is called Niddah and may be banned from certain actions. For example, the Jewish Torah prohibits sexual intercourse with a menstruating woman.[95] In Hinduism, menstruating women are traditionally considered ritually impure and given rules to follow.[96][97] In Zoroastrianism, if a woman's menses did not stop after nine days, it was considered the work of the daēvas.[98]

Menstruation education is frequently taught in combination with sex education at school in Western countries, although girls may prefer their mothers to be the primary source of information about menstruation and puberty.[99] Information about menstruation is often shared among friends and peers, which may promote a more positive outlook on puberty.[100] The quality of menstrual education in a society determines the accuracy of people's understanding of the process.[101] In many Western countries where menstruation is a taboo subject, girls tend to conceal the fact that they may be menstruating and struggle to ensure that they give no sign of menstruation.[101] Effective educational programs are essential to providing children and adolescents with clear and accurate information about menstruation. Schools can be an appropriate place for menstrual education to take place.[102] Programs led by peers or third-party agencies are another option.[102] Low-income girls are less likely to receive proper sex education on puberty, leading to a decreased understanding of why menstruation occurs and the associated physiological changes that take place. This has been shown to cause the development of a negative attitude towards menstruation.[103]

Seclusion during menstruation

[edit]
Further information: Chhaupadi and Seclusion of girls at puberty
Awareness raising through education is taking place among women and girls to modify or eliminate the practice of chhaupadi in Nepal.

In some cultures, women were isolated during menstruation due to menstrual taboos.[104] This is because they are seen as unclean, dangerous, or bringing bad luck to those who encounter them. These practices are common in parts of South Asia including India.[105] A 1983 report found women refraining from household chore during this period in India.[106] Chhaupadi is a social practice that occurs in the western part of Nepal for Hindu women, which prohibits a woman from participating in everyday activities during menstruation. Women are considered impure during this time and are kept out of the house and have to live in a shed. Although chhaupadi was outlawed by the Supreme Court of Nepal in 2005, the tradition is slow to change.[107][108] Women and girls in cultures which practice such seclusion are often confined to menstruation huts, which are places of isolation used by cultures with strong menstrual taboos. The practice has recently come under fire due to related fatalities. Nepal criminalized the practice in 2017 after deaths were reported after the elongated isolation periods, but "the practice of isolating menstruating women and girls continues."[109] Not all cultures villainize menstruation, the Beng people of West Africa consider menstrual blood as sacred and recognize its significance in reproduction.[110]

Beliefs around synchrony

[edit]

Effects of the moon

[edit]
See also: Lunar effect

Even though the average length of the human menstrual cycle is similar to that of the lunar cycle, in modern humans there is no relation between the two.[111] The relationship is believed to be a coincidence.[112][113] Light exposure does not appear to affect the menstrual cycle in humans.[114] A meta-analysis of studies from 1996 showed no correlation between the human menstrual cycle and the lunar cycle,[115] nor did data analyzed by period-tracking app Clue, submitted by 1.5 million women, of 7.5 million menstrual cycles; however, the lunar cycle and the average menstrual cycle were found to be basically equal in length.[116]

Cohabitation

[edit]

Beginning in 1971, some research suggested that menstrual cycles of cohabiting women became synchronized (menstrual synchrony).[117] Subsequent research has called this hypothesis into question.[118] A 2013 review concluded that menstrual synchrony likely does not exist.[119]

Work

[edit]

Some countries, mainly in Asia, have menstrual leave to provide women with either paid or unpaid leave of absence from their employment while they are menstruating.[120] Countries with policies include Japan, Taiwan, Indonesia, and South Korea.[121][122] The practice is controversial due to concerns that it bolsters the perception of women as weak, inefficient workers,[120] as well as concerns that it is unfair to men,[123][124] and that it furthers gender stereotypes and the medicalization of menstruation.[121]

Other mammals

[edit]
Main articles: Menstrual cycle § Evolution and other species, and Menstruation (mammal)

Most female mammals have an estrous cycle, but not all have a menstrual cycle that results in menstruation. Menstruation in mammals occurs in some close evolutionary relatives such as chimpanzees.[125]

See also

[edit]
  • Niddah (Jewish laws of menstruation)

References

[edit]

Sources

[edit]
  • Else-Quest N, Hyde JS (2021). "Psychology, gender, and health: psychological aspects of the menstrual cycle". The Psychology of Women and Gender: Half the Human Experience (10th ed.). Los Angeles: SAGE Publishing. ISBN 978-1-544-39360-5.
  • Prior JC (2020). "The menstrual cycle: its biology in the context of silent ovulatory disturbances". In Ussher JM, Chrisler JC, Perz J (eds.). Routledge International Handbook of Women's Sexual and Reproductive Health (1st ed.). Abingdon, Oxon: Routledge. ISBN 978-1-138-49026-0. OCLC 1121130010.

Further reading

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Menstruation

View on Grokipedia
from Grokipedia
Menstruation is the shedding of the functional layer of the uterine endometrium, accompanied by vaginal bleeding, that occurs cyclically in non-pregnant human females of reproductive age following the luteal phase of the ovarian cycle.[1] This process marks the onset of the menstrual cycle, a coordinated sequence of hormonal events preparing the reproductive system for potential pregnancy.[2] The average menstrual cycle length, based on large-scale tracking data, is approximately 29 days, though it typically ranges from 21 to 35 days, with individual variation influenced by factors such as age and health.[3][4] The menstrual cycle is regulated by the interplay of gonadotropin-releasing hormone from the hypothalamus, follicle-stimulating hormone and luteinizing hormone from the anterior pituitary, and ovarian steroids including estrogen and progesterone.[5] In the follicular phase, rising estrogen levels promote endometrial proliferation; ovulation follows a luteinizing hormone surge, after which the corpus luteum secretes progesterone to maintain the endometrium.[2] Absent implantation, declining progesterone triggers endometrial breakdown and menstruation, lasting 3 to 7 days with blood loss averaging 30-40 milliliters.[5] This cycle serves as a vital sign of endocrine and reproductive health, with irregularities often indicating underlying conditions like polycystic ovary syndrome or thyroid dysfunction.[6] Evolutionarily, menstruation may represent a costly but adaptive mechanism, potentially evolved to protect against uterine pathogens introduced via insemination or as a byproduct of thick endometrial preparation for implantation in species with invasive placentation.[7] Empirical studies highlight its rarity among mammals, occurring visibly in humans and a few primates, underscoring its link to hemochorial placentation and high energetic investment in reproduction.[8] While culturally stigmatized in some societies, menstruation fundamentally signals fertility and ovulatory function, with suppression via hormonal contraceptives representing a modern intervention altering natural cyclicity.[1]

Biological Definition and Physiology

Definition and Species Occurrence

Menstruation is the periodic shedding of the endometrium, the inner lining of the uterus, resulting in vaginal discharge of blood, mucus, and tissue fragments, which occurs in reproductively mature females of certain mammalian species in the absence of pregnancy.[2] This process is triggered by a decline in progesterone levels following the regression of the corpus luteum, leading to localized endometrial breakdown and expulsion.[9] In humans, this process occurs universally in females of reproductive age with functioning ovaries and uterus, regardless of race or ethnicity, with no biological basis for racial differences preventing menstruation. It typically begins at menarche, around age 12 on average, and continues monthly until menopause, approximately age 51, unless interrupted by pregnancy, lactation, or other factors.[4] Menstruation is rare among mammals, documented in fewer than 2% of species, or roughly 85 known cases, predominantly among primates.[10] It occurs in haplorhine primates, including humans (Homo sapiens), great apes such as chimpanzees (Pan troglodytes), gorillas (Gorilla gorilla), and orangutans (Pongo spp.), as well as Old World monkeys like baboons (Papio spp.) and macaques (Macaca spp.); some New World monkeys in genera such as Cebus and Ateles also exhibit it.[11] Outside primates, menstruation has been observed in elephant shrews (order Macroscelidea), the Cairo spiny mouse (Acomys cahirinus), and 3 to 5 bat species, including certain emballonurids and phyllostomids.[12] These instances represent evolutionary convergences, with no menstruation reported in other mammalian orders like rodents (beyond the spiny mouse), carnivores, or artiodactyls, which instead rely on estrous cycles with concealed endometrial resorption.[13] The scarcity underscores menstruation's specialization, potentially linked to thick endometrial development for implantation in species with high miscarriage risks or invasive placentation.[14]

Menstrual Cycle Phases

The menstrual cycle typically lasts 28 days, though it ranges from 21 to 35 days in reproductive-age females, and is regulated by interactions between the hypothalamus, pituitary gland, and ovaries.[2] It encompasses ovarian and endometrial changes divided into the menstrual phase, follicular phase, ovulation, and luteal phase.[5] The menstrual phase begins on day 1 with the onset of bleeding and lasts 3 to 7 days on average.[4] It involves the shedding of the functional layer of the endometrium due to declining levels of progesterone and estrogen following corpus luteum regression in the absence of pregnancy.[2] Blood loss during this phase averages 20 to 90 ml.[15] The follicular phase overlaps with the menstrual phase and extends from day 1 until ovulation, typically lasting 10 to 16 days with variability primarily affecting cycle length.[5] Follicle-stimulating hormone (FSH) from the anterior pituitary stimulates the growth of ovarian follicles, one of which becomes dominant; rising estrogen from the follicles promotes endometrial proliferation and feedback inhibits FSH while eventually triggering a luteinizing hormone (LH) surge.[2] Ovulation occurs approximately midway through the cycle, around day 14 in a 28-day cycle, triggered by a mid-cycle surge in LH that causes rupture of the mature follicle and release of the oocyte into the fallopian tube.[5] This event lasts about 24 hours for oocyte viability but defines the fertile window spanning 5 days before to 1 day after.[16] The luteal phase follows ovulation and lasts 12 to 14 days, relatively fixed in duration across cycles.[5] The ruptured follicle transforms into the corpus luteum, which secretes progesterone to maintain the endometrial lining for potential implantation and inhibits further ovulation via negative feedback on gonadotropins; if no implantation occurs, the corpus luteum involutes, hormone levels drop, and menstruation ensues.[2]

Hormonal and Physiological Mechanisms

The hormonal and physiological mechanisms of menstruation are orchestrated by the hypothalamic-pituitary-ovarian (HPO) axis, which regulates the menstrual cycle through pulsatile gonadotropin-releasing hormone (GnRH) secretion from the hypothalamus. GnRH stimulates the anterior pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which in turn act on the ovaries to drive follicular development, ovulation, and corpus luteum formation.[2][5] In the follicular phase, FSH promotes the growth of ovarian follicles, leading to rising estradiol (estrogen) levels that exert negative feedback on FSH secretion while stimulating endometrial proliferation. A mid-cycle surge in LH, triggered by positive feedback from peak estradiol, induces ovulation approximately 36 hours later. Post-ovulation, the ruptured follicle forms the corpus luteum, which secretes progesterone to maintain the secretory transformation of the endometrium and inhibit further gonadotropin release via negative feedback.[2][5] Menstruation ensues in the absence of pregnancy when the corpus luteum regresses around day 24-26 of a typical 28-day cycle, causing abrupt declines in progesterone and estradiol concentrations. This hormonal withdrawal destabilizes the endometrium: progesterone cessation removes suppression of inflammatory mediators, leading to elevated prostaglandin F2α production, which induces arteriolar vasoconstriction, endometrial ischemia, and focal hemorrhage.[2][17] Physiologically, the shedding involves enzymatic degradation of the extracellular matrix by matrix metalloproteinases (MMPs), particularly MMP-1, -3, and -9, activated in stromal cells and leukocytes infiltrating the decidua. Hypoxia from ischemia further upregulates MMP expression and proinflammatory cytokines like interleukin-8, fragmenting the functionalis layer while sparing the basalis for regeneration. This process typically lasts 3-7 days, with menstrual fluid comprising blood, endometrial cells, and mucin-stabilized thrombi, expelled via uterine contractions mediated by prostaglandins.[17][18][19]

Characteristics of the Menstrual Event

Duration, Frequency, and Fluid Properties

The duration of menstrual bleeding in healthy women typically lasts 3-7 days (sometimes 2-8 days), with heavier flow concentrated in the first 2-3 days before tapering, a median of 5 days, and heavier flow often concentrated in the first 3 days.[2] [20] [21] Bleeding lasting 8 days or less falls within normal physiological variation, though durations shorter than 4 days or exceeding 7 days occur in fewer than 5% of cycles among regularly menstruating women; bleeding over 8 days may require medical evaluation.[22] [6] Individual factors such as age, hormonal status, and underlying conditions influence this range; for instance, cycles in adolescents may initially feature shorter or irregular durations that stabilize by the third year post-menarche.[6] Menstruation recurs with a cycle length of 21 to 35 days in most ovulatory women, measured from the first day of one bleeding episode to the first day of the next.[4] [21] This frequency aligns with the hormonal orchestration of the ovarian and endometrial cycles, where ovulation typically occurs mid-cycle, prompting endometrial shedding if no implantation follows. Cycle lengths outside 24 to 38 days may indicate anovulation or other disruptions, though variation of 4 to 11 days within individuals is common, particularly influenced by age and environmental factors.[23][24] Menstrual fluid is a composite biological material comprising approximately 36% to 50% blood (primarily arterial with some venous components), alongside endometrial tissue fragments, cervical mucus, vaginal secretions, cellular debris, and prostaglandins.[25] [26] The average total fluid volume per cycle is 5 to 80 mL, with blood loss specifically in the normal range of 20-80 mL—equivalent to a few fully soaked pads—and averaging 30 to 40 mL, rarely exceeding 80 mL without qualifying as abnormal.[27] [28] [29] This fluid exhibits variable properties, including a pH of around 7.4, potential for clotting due to fibrin, and colors ranging from bright red (fresh blood) to dark brown or black (oxidized older blood, often appearing at the onset when flow is slower), reflecting the dynamic shedding and expulsion process. Both thick and thin consistencies of menstrual blood are typically normal and healthy, varying naturally due to flow speed, time spent in the uterus, and mixing with cervical mucus or uterine lining; thin or watery blood often accompanies faster flow such as fresh bright red blood or at the start/end of a period, while thick, stringy, jelly-like, or clotted blood occurs with slower flow, heavier days, or small clots up to quarter-sized that help prevent excessive bleeding.[30] [31] Clots and thicker, viscous discharge are common, arising from endometrial tissue fragments and natural coagulation, especially during heavier flow or at the beginning of menstruation; these are typically normal physiological variations.[30] [31] However, gynecological consultation is recommended if there is excessively heavy bleeding, frequent or large clots (larger than a quarter), severe pain, or prolonged duration, as these may indicate conditions such as uterine fibroids or endometriosis.[32] [31]

Normal Symptoms and Individual Variations

Common symptoms during menstruation include lower abdominal cramping, known as dysmenorrhea, which affects 50% to 90% of women of reproductive age and is often accompanied by back pain, headache, nausea, and fatigue.[33] Dysmenorrhea typically begins within hours of menstrual onset, peaks in intensity within 24 hours, and lasts 48 to 72 hours, resulting from uterine contractions driven by prostaglandins.[34] Additional physical symptoms may involve bloating due to fluid retention and gastrointestinal changes such as diarrhea or constipation, reported in up to 73% of cycles.[35] A common variation in menstrual flow is a sudden gush of blood when changing to a new pad, caused by gravity facilitating the discharge of blood accumulated in the uterus or vagina during periods of immobility or different positioning; this is a normal physiological phenomenon and not indicative of abnormality. Premenstrual symptoms, occurring in the luteal phase prior to bleeding, encompass a range of somatic and psychological effects classified under premenstrual syndrome (PMS), experienced by 75% to 80% of menstruating women to some degree.[36] These include breast tenderness, food cravings, irritability, anxiety, depressed mood, and sleep disturbances, with mood-related symptoms like irritability and mood swings prevalent in 70% to 80% of affected individuals.[37] Fatigue and poor concentration are also frequent, impacting daily functioning in moderate to severe cases for 5% to 12% of women.[38] Brown spotting or discharge before menstruation, including premenstrual spotting (light blood spotting before the expected period), is common and often normal, typically occurring from a few days to one to two weeks prior to the period; a short 2-day delay in menstruation is typically within normal cycle variation.[21] When accompanied by lower abdominal pain, these symptoms often have benign causes such as normal hormonal fluctuations or premenstrual changes causing light spotting and mild cramps, stress, illness, or lifestyle factors leading to minor cycle irregularities. Possible other causes include early pregnancy, particularly implantation bleeding (light pink/brown spotting lasting 1-2 days around the expected period with mild cramping), or ovulation-related spotting or mittelschmerz (one-sided lower abdominal pain mid-cycle, though less likely with a delay).[39] Underlying conditions such as polycystic ovary syndrome (PCOS), endometriosis, uterine fibroids/polyps, thyroid issues, or infections (e.g., STIs or pelvic inflammatory disease) may cause irregular bleeding, spotting, delays, and pelvic pain. Additional causes include old blood from the previous cycle exiting slowly, mid-cycle hormonal changes around two weeks before the period, or the onset of menstruation where lighter bleeding mixes with discharge to appear brown.[40][41] Conversely, the absence of usual premenstrual brown spotting alone does not reliably indicate pregnancy, but such a change in pattern may suggest it if accompanied by a missed period or other early symptoms like breast tenderness or fatigue, owing to hormonal stabilization halting typical premenstrual shedding.[42] Factors including stress, birth control, or ovulation variations can also alter spotting. These symptoms are frequently harmless, especially with only a 2-day delay and mild pain, but persistent, heavy, worsening, or unusual symptoms warrant medical evaluation to rule out pregnancy or other conditions, with pregnancy best confirmed via home test or consultation.[43] Individual variations in symptom experience are substantial, with some women reporting minimal or no discomfort while others encounter debilitating pain or mood alterations; cycle-to-cycle fluctuations account for 79% to 98% of mood symptom variance, often deviating from predictable premenstrual exacerbation patterns.[44] Factors influencing variability include age, with symptoms peaking in the 20s to 30s and potentially attenuating post-parity or with hormonal contraceptives; higher body mass index correlates with increased dysmenorrhea severity, while regular physical activity may mitigate it.[45] Genetic predispositions, stress levels, and lifestyle elements such as smoking or caffeine intake further modulate symptom intensity and prevalence, underscoring the spectrum of physiological responses across populations.[46]

Evolutionary and Comparative Biology

Theories on the Evolution of Menstruation

Several hypotheses have been proposed to explain the evolution of overt menstruation in humans and a few other primates, a trait absent in the vast majority of mammals, which instead reabsorb endometrial tissue without shedding.[11] These theories generally posit adaptive benefits outweighing the energetic costs, estimated at approximately 10% of a woman's caloric intake per cycle due to tissue buildup and expulsion, including significant iron loss. Menstruation likely evolved independently multiple times, occurring in less than 2% of mammalian species, suggesting convergent selection pressures related to reproductive physiology.[11] One prominent theory, advanced by anthropologist Beverly Strassmann, argues that menstruation functions as a defense mechanism against pathogens transmitted via semen, dislodging infected endometrial tissue to protect the uterus and oviducts from ascending infections.[47] This hypothesis draws on comparative data showing higher pathogen loads in promiscuous mating systems and empirical observations from Strassmann's longitudinal studies of the Dogon people in Mali, where menstrual blood loss correlates with environmental pathogen pressures rather than mere waste disposal.[48] Strassmann further contends that the energy expenditure of shedding, rather than reabsorbing, tissue is adaptive in species with concealed ovulation and frequent cycling, as it prevents chronic infections that could impair fertility more severely than periodic blood loss. Critics note that this model assumes high historical STD prevalence, though supporting evidence includes elevated uterine infection risks in non-menstruating mammals post-mating.[47] An alternative framework, proposed by evolutionary geneticist Deena Emera and colleagues, views menstruation as a byproduct of genetically assimilated spontaneous decidualization—the preemptive thickening of the endometrium without embryonic signaling—allowing proactive preparation for highly invasive human implantation.[11] In this model, failed pregnancies trigger inflammatory shedding to avoid retaining defective or non-viable embryos, which could otherwise lead to pathological retention or neoplasia; this stabilization occurred after decidualization shifted from embryo-induced (in most mammals) to spontaneous in anthropoid primates.[49] Genomic analyses support this, revealing conserved molecular pathways for inflammation and tissue rejection in menstruating lineages, with menstruation enabling rejection of suboptimal implantations to enhance offspring quality amid energetically costly human gestation.[11] Empirical backing includes observations that human embryos invasively remodel uterine arteries, necessitating robust clearance mechanisms absent in species with superficial implantation.[50] A related implantation-focused hypothesis posits menstruation evolved to mitigate risks from the aggressive trophoblast invasion unique to humans, where partial or faulty embedding damages the endometrium, prompting shedding to prevent complications like retained products or chronic inflammation. This aligns with comparative physiology: non-menstruating mammals exhibit minimal endometrial turnover, while human cycles accommodate uncertain fertilization timing in concealed ovulation species.[51] However, direct tests remain limited, with some models critiqued for overemphasizing costs without quantifying pathogen or implantation failure rates in ancestral environments.[52] Overall, these theories converge on menstruation as an adaptation for high-fidelity reproduction, trading periodic losses for reduced long-term reproductive morbidity.[11][47]

Menstruation Versus Estrous Cycles in Mammals

Menstruation occurs in a small minority of mammalian species, primarily certain primates, while the vast majority exhibit estrous cycles without overt endometrial shedding. In estrous cycles, characteristic of most mammals such as rodents, carnivores, and ungulates, the uterine endometrium proliferates during the luteal phase under progesterone influence but is largely reabsorbed or minimally degraded if implantation does not occur, avoiding significant blood loss.[14][12] This process contrasts with menstruation, where the endometrium undergoes extensive necrosis and shedding, resulting in visible bleeding through the vagina.[13] Estrous cycles typically feature discrete phases—proestrus, estrus (heat, marked by behavioral receptivity and ovulation), metestrus, and diestrus—with females sexually receptive only during estrus, often accompanied by overt signaling like vulvar swelling or pheromones.[53][54] The menstrual cycle, observed in humans, other haplorhine primates (e.g., Old World monkeys and apes), some bats (e.g., four species including Pallas's long-tongued bat), the elephant shrew, and the spiny mouse (Acomys cahirinus), involves endometrial desquamation at cycle end if pregnancy fails, with blood loss averaging 30-80 mL in humans.[10][13] Approximately 85 mammalian species, or less than 2% of known placental mammals, exhibit menstruation, with over 98% relying on estrous mechanisms.[10][12] Unlike estrous cycles, menstrual cycles often lack strict behavioral estrus; in humans, ovulation is concealed, and sexual receptivity persists across phases, decoupling mating from peak fertility signals.[55] Cycle lengths vary more in menstruating species—the human cycle averages 28 days but ranges 21-35 days—compared to the relatively fixed estrous intervals in non-menstruating mammals, such as 21 days in cows or 4-5 days in mice.[53][56] Physiological differences extend to endometrial histology and hormone dynamics. Estrous endometria show spiral artery development but regress via apoptosis and phagocytosis without widespread hemorrhage, conserving energy and minimizing infection risk from blood exposure.[14] Menstruating species, however, evolve thicker endometria with more extensive vascularization, leading to focal ischemia, necrosis, and expulsion upon progesterone withdrawal, potentially as an adaptive response to pathogen clearance or implantation failure detection.[13][12] Luteal phases are generally shorter and less variable in estrous cycles, while follicular phases dominate variability in menstrual cycles, influencing overall cycle predictability.[56] These distinctions highlight menstruation's rarity, likely tied to evolutionary trade-offs in reproductive strategy among mammals.[14]

Health Implications and Disorders

Short-Term Physiological Effects

Menstruation commences with the withdrawal of progesterone and estrogen support in the absence of pregnancy, prompting vasoconstriction of endometrial spiral arterioles, ischemia, and enzymatic degradation of the functional endometrial layer. This leads to the shedding and expulsion of approximately 10-15 mm of tissue depth, primarily from the luminal two-thirds of the endometrium, mixed with blood and mucus to form menstrual effluent. The process involves localized inflammation, matrix metalloproteinase activation, and leukocyte infiltration, resembling a controlled wound breakdown followed by rapid re-epithelialization without scarring.[2][17][19] Uterine smooth muscle contractions intensify during this phase due to elevated endometrial synthesis of prostaglandins, particularly PGF2α, which peaks at menses onset and promotes myometrial hyperactivity, arteriolar constriction, and pain via sensitization of nociceptors. These contractions, averaging 3-5 per 10 minutes and strongest on days 1-2, expel debris but can cause dysmenorrhea in up to 90% of women, characterized by lower abdominal cramping radiating to the back or thighs; severity correlates with prostaglandin levels, with higher concentrations linked to ischemia-induced pain. Systemically, prostaglandins may induce gastrointestinal effects like diarrhea or nausea by stimulating intestinal smooth muscle.[57][58][59] Blood loss during a typical cycle ranges from 30 to 50 mL, comprising about 36% of total effluent volume, with heavier flows (up to 80 mL) still physiologically normal but potentially causing transient fatigue, pallor, or orthostatic symptoms from acute volume depletion in susceptible individuals. Iron loss averages 15-20 mg per cycle, insufficient for immediate anemia in most but contributing to cumulative depletion if uncompensated; empirical data show no significant short-term alterations in heart rate, oxygen uptake, or core temperature solely from normal menses. Hormonal nadirs sustain low energy or mild mood dips in some, though large-scale analyses find no consistent cognitive or performance impairments attributable to this phase.[60][61]

Common Menstrual Disorders

Dysmenorrhea, the medical term for painful menstrual cramps, is one of the most prevalent menstrual complaints, affecting women through prostaglandin-induced uterine contractions that cause ischemia and pain. Primary dysmenorrhea, lacking underlying pelvic pathology, typically emerges shortly after menarche and resolves with nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen, which inhibit prostaglandin production causing uterine contractions; these are taken at the onset of pain or preemptively before the period as per instructions, with 20-30 minute onset and effects lasting hours, though individuals with stomach issues or allergies should consult a doctor.[62][59] Its global prevalence ranges from 16% to 91% among reproductive-age women, with severe forms impacting 2% to 29% and often leading to absenteeism or reduced productivity.[63] [64] Secondary dysmenorrhea arises from conditions such as endometriosis or fibroids, with prevalence influenced by age and comorbidities; for instance, up to two-thirds of adolescents with chronic pelvic pain may have endometriosis-related secondary dysmenorrhea.[65] Heavy menstrual bleeding (menorrhagia), defined as menstrual blood loss exceeding 80 mL per cycle or lasting longer than seven days, disrupts daily activities and risks iron-deficiency anemia due to excessive endometrial shedding or impaired hemostasis. Structural causes include uterine fibroids (leiomyomas), polyps, and adenomyosis, while dysfunctional uterine bleeding from anovulatory cycles or hormonal imbalances accounts for roughly 80% of cases without identifiable lesions. Coagulation disorders like von Willebrand disease contribute in 10-20% of adolescents with severe bleeding. Prevalence varies by population but affects an estimated 10-30% of reproductive-age women globally, with higher rates in regions with limited diagnostic access.[66] [67] [68] Amenorrhea, the absence of menstruation, is classified as primary (no menarche by age 15-16 despite secondary sexual development) or secondary (cessation for three months in previously menstruating women, or six months if cycles were irregular). Primary amenorrhea has an incidence below 1% in the United States, often stemming from chromosomal anomalies like Turner syndrome or Müllerian agenesis. Secondary amenorrhea, more common, affects 3-5% of reproductive-age women and frequently results from hypothalamic suppression (e.g., due to excessive exercise or low body weight), polycystic ovary syndrome (prevalence 6-10%), or hyperprolactinemia. Pregnancy remains the leading cause, excluding transient cases from stress or medications.[69] [70] [71] Premenstrual syndrome (PMS) encompasses physical and psychological symptoms like bloating, irritability, and fatigue occurring cyclically in the luteal phase, resolving post-menses; severe variants qualify as premenstrual dysphoric disorder (PMDD) with marked mood disturbances meeting DSM criteria. PMS symptoms affect up to 12% of women severely enough to impair function, linked to serotonin fluctuations and ovarian hormone sensitivity rather than absolute levels. PMDD prevalence is 3-8% among menstruating individuals, with confirmed diagnoses around 1.6-3.2% in rigorous studies, disproportionately impacting those with trauma histories or axis I psychiatric disorders.[38] [72] [73] Endometriosis, involving ectopic endometrial tissue growth causing inflammation and scarring, manifests as secondary dysmenorrhea, chronic pelvic pain, or infertility in 30-50% of cases, with menstrual exacerbation due to retrograde menstruation and immune dysregulation. It affects approximately 10% (190 million) of reproductive-age women worldwide, though underdiagnosis persists due to invasive laparoscopy requirements for confirmation.[74] [75]

Interactions with Other Health Conditions

Heavy menstrual bleeding can lead to iron deficiency anemia, as blood loss depletes iron stores, resulting in symptoms such as fatigue, headaches, and reduced oxygen-carrying capacity in red blood cells; this is the most common cause of iron deficiency in reproductive-aged women, affecting up to 40% of adolescents with heavy flows.[76][67] Hypothyroidism often manifests with menorrhagia or oligomenorrhea due to disrupted hormonal regulation of endometrial shedding, while hyperthyroidism is associated with hypomenorrhea; these patterns arise from thyroid hormones' influence on gonadotropin release and ovarian function, with over half of hypothyroid women experiencing irregularities.[77][78][79] In women with epilepsy, catamenial patterns occur where seizures increase during perimenstrual phases (days -3 to +3), the ovulatory period, or luteal phase, impacting approximately 40% of cases due to estrogen's proconvulsant effects contrasting progesterone's anticonvulsant properties; this hormonal interplay heightens seizure susceptibility when estrogen peaks or progesterone withdraws.[80][81] Catamenial migraines, triggered by the premenstrual estrogen drop, affect women with migraine history, occurring from two days before to three days after menses onset in at least two of three cycles, often more severe and less responsive to standard treatments than non-menstrual attacks.[82][83] Irregular or prolonged menstrual cycles correlate with elevated cardiovascular disease risk, including a 19-20% higher incidence of heart disease and atrial fibrillation, linked to underlying insulin resistance, dyslipidemia, and hypertension rather than menstruation per se; heavy bleeding further compounds this via chronic iron loss and inflammation.[84][85][86] In diabetes, long cycles predict type 2 onset, particularly in obese women, while type 1 patients face glycemic variability—insulin sensitivity decreases in the luteal phase, causing blood sugar spikes treatable with adjusted dosing.[87][88][89] Autoimmune conditions like systemic lupus erythematosus or Hashimoto's thyroiditis exhibit perimenstrual flares, driven by progesterone withdrawal and immune activation in the luteal-to-menstrual transition, intensifying joint pain, fatigue, and rashes; cycle irregularities also signal heightened disease activity via altered regulatory T-cell function.[90][91][92] Premenstrual dysphoric disorder (PMDD), a severe PMS variant, overlaps with major depression and anxiety, with affected women showing 2-6 times higher lifetime mood disorder risk, attributable to serotonin dysregulation amplified by luteal-phase neurosteroid changes rather than primary psychiatric etiology.[93][94]

Management and Medical Interventions

Hygiene Practices and Products

Menstrual hygiene practices center on using absorbent or collection products to manage vaginal blood flow while minimizing infection risk, odor, and leakage through regular changing and hand hygiene. The U.S. Centers for Disease Control and Prevention (CDC) recommends washing hands before and after handling products and changing them frequently based on flow to prevent bacterial growth.[95] Common products include disposable pads, tampons, menstrual cups, and reusable options like cloth pads or underwear. Disposable sanitary pads, worn externally in underwear, consist of an absorbent core of cellulose or superabsorbent polymers topped with a permeable layer and backed by plastic to prevent leaks. They typically require changing every 4 to 8 hours, or more often during heavy flow, to avoid skin irritation or infection from prolonged moisture exposure.[96] Tampons, inserted into the vagina, are made from compressed cotton, rayon, or blends and expand to absorb blood internally, with capacities varying by size from 5 to 30 milliliters. To mitigate risks like menstrual toxic shock syndrome (TSS)—linked to Staphylococcus aureus toxin production—tampons should be changed every 4 to 6 hours, avoided overnight continuously, and alternated with pads; post-1980 FDA regulations on absorbency reduced U.S. TSS cases from over 800 annually to fewer than 50 by the 1990s.[97] [98] Menstrual cups, reusable devices of medical-grade silicone or rubber inserted to form a seal and collect blood, hold 20 to 30 milliliters and can be emptied every 4 to 12 hours depending on flow. Systematic reviews confirm their safety and efficacy, with no reported TSS cases in large studies and leakage rates comparable to or lower than tampons when fitted properly, though users with intrauterine devices face a potential expulsion risk requiring counseling.30111-2/fulltext) [99] Reusable cloth pads or menstrual underwear, made from layered fabrics like cotton or bamboo, absorb externally and must be changed every 4 to 6 hours, then washed with soap to remove blood and bacteria; life-cycle assessments show they generate 80 to 90 percent less waste and carbon emissions than disposables over multiple years, though improper cleaning can harbor pathogens.[100] [101] Proper disposal involves wrapping used disposables in paper before binning to contain odor and prevent scavenging, while reusables demand immediate rinsing and machine washing to maintain hygiene; globally, inadequate practices contribute to environmental pollution, with disposable pads comprising up to 90 percent plastic that persists in landfills for centuries.[102] Evidence from cohort studies emphasizes that consistent hygiene reduces vulvovaginal infections, underscoring the causal link between prolonged product wear and microbial overgrowth irrespective of product type.[103]

Physical Activity During Menstruation

Light exercises on the first day of menstruation, including walking, yoga, Pilates, gentle stretching, or light cardio, are recommended to reduce cramps, bloating, fatigue, and mood swings via endorphin release and improved blood flow. High-intensity or strenuous workouts should be avoided if heavy flow, severe cramps, or discomfort occur; rest should be prioritized by attending to bodily cues.[104][105]

Methods of Menstrual Suppression

Menstrual suppression refers to the intentional reduction or elimination of menstrual bleeding through hormonal interventions that stabilize the endometrial lining or inhibit cyclic hormonal fluctuations. These methods primarily involve progestin-dominant or combined estrogen-progestin contraceptives, which prevent ovulation and minimize endometrial buildup. Continuous or extended regimens, rather than cyclic use with placebo intervals, are employed to avoid withdrawal bleeding.[106][107] Combined estrogen-progestin contraceptives, such as oral pills, transdermal patches, or vaginal rings, achieve suppression via extended cycles where active hormone phases are prolonged without hormone-free intervals. For oral contraceptives, users skip placebo pills and proceed directly to a new pack, resulting in breakthrough bleeding that typically diminishes over time; amenorrhea rates increase with prolonged use. This approach has been utilized since the development of combination pills in the 1960s, with clinical evidence supporting its safety for indefinite continuation in eligible individuals.[108][109][107] Progestin-only methods offer alternatives for those contraindicating estrogen, often yielding higher amenorrhea rates due to direct endometrial thinning. Depot medroxyprogesterone acetate (DMPA, Depo-Provera), administered as intramuscular or subcutaneous injections every 12-13 weeks, induces amenorrhea in 55% of users by month 12 and 68% by month 24. Levonorgestrel-releasing intrauterine devices (LNG-IUDs, e.g., Mirena at 52 mg), inserted for up to 5-8 years, reduce bleeding progressively, with approximately 20% of users experiencing amenorrhea after three or more months. Subdermal implants like etonogestrel (Nexplanon), lasting up to 3 years, and progestin-only pills also contribute to suppression, though with variable initial spotting that improves to 80-90% amenorrhea or reduced bleeding by months 10-12 in many cases.[110][111][112] These methods are selected based on patient preferences, contraindications, and desired duration, with progestin-only options preferred for breastfeeding individuals or those with estrogen-related risks. Efficacy in suppression correlates with adherence and method-specific pharmacokinetics, such as steady progestin release preventing cyclic changes.[106][113]

Risks and Evidence on Suppression Outcomes

Menstrual suppression via continuous or extended regimens of combined hormonal contraceptives (CHC) or progestin-only methods, such as depot medroxyprogesterone acetate (DMPA), levonorgestrel-releasing intrauterine devices (LNG-IUD), or implants, achieves amenorrhea by inducing endometrial atrophy and inhibiting ovulation, with amenorrhea rates often increasing over time to 50-80% depending on the method.[113] [107] These approaches are deemed safe and effective for short- to medium-term use in reproductive-aged individuals without contraindications, with studies showing no significant impact on future fertility, as evidenced by an 83% pregnancy rate within 12 months post-discontinuation, comparable to non-users.[106] [113] Bone mineral density (BMD) concerns arise particularly with progestin-only methods like DMPA, which can cause significant BMD loss in the first year of use, especially in adolescents and young adults during peak bone accrual, with reductions up to 5-7% at the hip and spine; this loss is partially reversible after discontinuation but warrants monitoring and calcium/vitamin D supplementation.[114] [115] Continuous CHC regimens show minimal or no adverse BMD effects, as estrogen components help preserve density.[106] Long-term progestin-only suppression is generally avoided in those under 18 or with risk factors for osteoporosis due to these findings.[106] Cardiovascular risks vary by method: CHC continuous use carries a small elevated risk of venous thromboembolism (VTE), similar to cyclic use (3-9 cases per 10,000 woman-years), influenced more by estrogen dose than suppression pattern, while progestin-only options like LNG-IUD or implants show no increased VTE, stroke, or myocardial infarction risk compared to non-users.[116] [117] Progestin-only pills and injections do not elevate blood pressure or overall cardiovascular disease incidence, making them preferable for those with hypertension or cardiac conditions.[118] [119] Common adverse outcomes include initial breakthrough or unscheduled bleeding, affecting up to 50% early in use but resolving in most by 6-12 months, alongside reports of headaches, abdominal pain, and mood changes, though these do not exceed cyclic regimen rates and contribute to discontinuation in 10-20% of users.[113] [120] Evidence indicates potential protective effects against endometrial and ovarian cancers from prolonged suppression due to reduced ovulatory cycles and thinner endometrium, with risk reductions of 20-50% observed in long-term users, though data on decades-long suppression remain limited.[121] Overall, while suppression alleviates dysmenorrhea and anemia in select cases, empirical outcomes emphasize individualized assessment, as long-term safety beyond 5-10 years lacks large-scale prospective trials.[106] [107]

Societal and Cultural Contexts

Historical and Cross-Cultural Practices

In ancient Egypt, menstruation was associated with both ritual impurity and divine connotations linked to the goddess Isis, with men excused from tomb construction if exposed to menstruating women due to beliefs that contact could contaminate sacred spaces.[122] Women likely managed flow using softened papyrus, lint, or other absorbent plant materials wrapped in linen, as evidenced by medical papyri and archaeological inferences, though direct artifacts are scarce.[123] In ancient Greece and Rome, humoral theory framed menstruation as a purging of excess blood to balance bodily fluids, with durations ideally three days; deviations were treated medically via fumigations or potions.[124] Roman sources like Pliny the Elder attributed potent properties to menstrual blood, claiming it could cure erysipelas when applied topically or blight crops if spilled, reflecting dual views of it as medicinal yet hazardous.[125] Hygiene involved wool tampons or linen rags secured by belts, but taboos restricted sexual activity and household duties during bleeding.[126] Medieval European practices relied on reusable rags, moss, or peat stuffed into undergarments, often laundered infrequently due to limited water access and bathing norms, leading to rudimentary hygiene without standardized products until the 19th century.[127] Church-influenced doctrines, drawing from Leviticus, deemed menstruating women ritually unclean, prohibiting communion or marital relations, though empirical evidence of health risks from poor sanitation was overlooked in favor of symbolic purity concerns.[128] Cross-culturally, seclusion practices persisted in South Asian Hindu and indigenous Nepali traditions, where women were isolated in menstrual huts (chhaupadi) to avoid polluting food, temples, or men, rooted in Vedic texts viewing blood as impure and dating to at least 1500 BCE.[129] In these systems, menstruants faced dietary bans on sour foods and restrictions from cooking or farming, with huts providing minimal shelter but exposing women to environmental hazards.[130] Among some Native American tribes in the southeastern U.S., 18th-century accounts describe menstrual lodges for seclusion, yet women often traveled or hunted during cycles, contradicting European colonial exaggerations of total isolation; blood was sometimes seen as spiritually potent rather than solely defiling.[131] In ancient and historical Chinese contexts, Confucian and Taoist influences barred menstruating women from sacred rituals or statue contact, equating blood with yin imbalance and uncleanliness, while hygiene used cloth pads or free absorption.[132] Anthropological surveys indicate taboos' prevalence correlates with patrilineal societies and agricultural economies, where blood's perceived fertility-disrupting potential prompted avoidance rituals, though hunter-gatherer groups like certain Australian Aboriginals treated menstruation neutrally or positively without seclusion.[133] In sub-Saharan African and Pacific Islander cultures, practices varied from using banana fibers or leaves for absorption to communal support without stigma, but colonial records often amplified impurity narratives to justify missionary interventions.[134] These patterns highlight causal links between menstrual visibility—tied to blood's biological messiness—and cultural mechanisms for social order, rather than inherent "uncleanness," with empirical hygiene limited by pre-industrial materials across regions.[126]

Rationales for Taboos and Seclusion

In numerous traditional societies, menstrual taboos and seclusion have been rationalized through beliefs in the ritual impurity or contaminating potency of menstrual blood, posited to defile food, water, sacred sites, or individuals upon contact. Among the Ufipa people of Tanzania, as documented in ethnographic studies, menstrual blood is conceptualized as a powerful substance capable of both cleansing and polluting, necessitating women's isolation from communal cooking and agricultural activities to avert crop failure or illness in others. Similarly, in Hindu-influenced practices in Nepal, the chhaupadi tradition requires women to reside in isolated huts during menstruation to contain this impurity, drawing from scriptural interpretations that associate the blood with temporary untouchability, thereby preserving household purity and familial well-being. These rationales, while varying by cultural context, often stem from pre-scientific understandings of blood as a vital yet hazardous fluid, though contemporary analyses highlight their reinforcement through patriarchal structures rather than verifiable sanitary mechanisms.[135] A secondary rationale emphasizes protection for the menstruating woman herself, framing seclusion as a provision of respite during physiological discomfort, fatigue, or vulnerability to exertion. Ethnographic accounts from hunter-gatherer groups suggest that periodic withdrawal from labor-intensive tasks like foraging allowed recovery from blood loss and cramps, potentially enhancing reproductive fitness by minimizing risks of injury or overexertion in a period of reduced strength. Proponents of this view, including examinations of indigenous practices, argue that such arrangements originally fostered group solidarity, with synchronized cycles enabling collective non-reproductive phases for cooperative endeavors, though empirical validation of menstrual synchrony as a widespread adaptive trait is contested due to small sample sizes and environmental confounders in observational data. In contrast, evolutionary hypotheses like those advanced by Chris Knight link taboos to enforced sexual abstinence, theorizing it maintained cycle alignment for synchronized group hunting among early hominids, but this remains speculative without fossil or genetic corroboration.[136][137] Additional rationales invoke the blood's symbolic association with life-death cycles or supernatural forces, warranting seclusion to harness or neutralize its influence. In some African and Oceanic cultures, menstrual blood is attributed magical properties—either curative or destructive—prompting isolation to prevent unintended harm, such as souring milk or wilting plants, as observed in cross-cultural anthropological surveys. These explanations, while empirically ungrounded in modern microbiology, may reflect intuitive recognition of bodily fluids' pathogen-carrying potential in eras lacking disinfection, where contact with open blood could facilitate transmission of infections like hepatitis via shared utensils or wounds; however, direct historical linkages between such awareness and taboos are inferential rather than documented. Where taboos persist, they often prioritize symbolic order over evidence-based hygiene, occasionally exacerbating health risks like malnutrition or exposure during seclusion.[135][138]

Debunked Myths and Empirical Realities

One persistent myth holds that women living in close proximity, such as roommates or family members, synchronize their menstrual cycles due to pheromones or social cues. Empirical studies, including reanalyses of dormitory data and longitudinal tracking of cohabiting pairs, have found no statistical evidence for this phenomenon, attributing apparent alignments to chance convergence within the limited 28-day cycle window rather than causal mechanisms.[139] [140] Another common belief is that premenstrual syndrome (PMS) symptoms are primarily psychological or exaggerated for behavioral excuses, dismissing them as non-biological. In reality, PMS involves verifiable somatic and affective changes tied to luteal-phase progesterone and estrogen fluctuations, with neuroimaging and hormonal assays showing altered brain activity in emotion-regulation regions; approximately 75-90% of menstruating women experience these, with severe variants like PMDD affecting 3-8% and responsive to targeted interventions like SSRIs.[141] [142] Academic sources on PMS have occasionally downplayed hormonal causality in favor of psychosocial models, but prospective daily-rating studies confirm cyclicity exceeds placebo effects or reporting biases.[37] The notion that menstrual blood loss is copious or debilitating for most women—often portrayed as equivalent to significant hemorrhage—is overstated. Controlled studies using alkaline hematin assays quantify average blood loss at 30-40 mL per cycle (total fluid ~70-80 mL), equivalent to a few tablespoons, with heavy menstrual bleeding defined as exceeding 80 mL and affecting only 10-30% of cases; this volume rarely causes anemia in iron-replete individuals absent underlying pathology.[143] [144] Claims that physical exertion during menstruation risks harm or diminishes performance lack substantiation and contradict evidence. Meta-analyses indicate exercise, including aerobic and resistance training, reduces dysmenorrhea intensity by up to 50% via endorphin release and improved pelvic circulation, with no phase-specific decrements in strength or endurance in eumenorrheic women; cycle-phase performance variations are minimal (<5%) and often attributable to individual factors like hydration rather than estrogen/progesterone alone.[145] [146] [147] Dietary restrictions, such as avoiding cold foods or dairy to prevent flow disruptions, stem from cultural folklore without physiological basis. Randomized trials and nutritional epidemiology find no causal links between specific ingestions and cycle parameters, as menstrual flow is governed by endometrial shedding independent of transient dietary effects beyond caloric deficits potentially delaying ovulation.[148]

Controversies and Policy Debates

Menstrual Equity and Period Poverty Claims

Advocates for menstrual equity assert that systemic barriers, including the cost of disposable products and taxation, exacerbate inequalities for those who menstruate, necessitating policies such as free provision in public facilities, schools, and workplaces, as well as exemptions from sales taxes on menstrual items.[149] These efforts gained traction in the late 2010s, with examples including Scotland's 2021 legislation mandating free products in public buildings and U.S. states like New York removing the "tampon tax" by 2022.[150] Claims of period poverty frame the issue as a public health crisis, positing that unaffordable products lead to missed school days, reduced productivity, and health risks like infections from improvised alternatives.[151] Survey-based evidence in developed countries reports varying degrees of access challenges, often concentrated among low-income or marginalized groups. In the United States, a 2019 national survey of teens aged 13-19 found 20% experienced trouble affording or accessing products at least once in the prior year, rising to 1 in 3 adults in some estimates from advocacy-led polls.[150][152] In the United Kingdom, a 2020 Plan International survey indicated 3 in 10 girls aged 14-21 struggled with affordability or access, with similar self-reported rates during economic disruptions like the COVID-19 quarantine.[153][151] A 2024 U.S. pediatric emergency department study reported 1 in 3 adolescent patients cited difficulties obtaining products.[154] Proponents link these figures to broader outcomes, such as 16.9 million U.S. menstruating individuals in poverty facing compounded food insecurity.[155] However, empirical scrutiny reveals limitations in these claims' scope and causality. Menstrual product costs average $20 per cycle or $66-84 annually for disposables in high-income settings, equating to under 0.2% of median female earnings in states like Colorado.[156][157] Such expenditures represent a minor share relative to overall household budgets, suggesting period poverty primarily manifests among the most economically vulnerable rather than as a widespread phenomenon independent of general deprivation.[158] Many surveys rely on self-reported "struggles," which may encompass temporary or perceived barriers rather than outright inability, and originate from advocacy organizations potentially incentivized to highlight deficits.[159] Policy responses like free distribution have shown mixed uptake, with studies indicating low preference for reusables among recipients and questions about long-term efficacy versus addressing root poverty drivers.[160] Critiques of the narrative emphasize opportunity costs and unintended effects, arguing that earmarked menstrual programs divert resources from universal welfare supports while framing a solvable hygiene issue as an identity-specific injustice.[161] In high-income contexts, anecdotal drivers underpin much policy momentum, with limited rigorous longitudinal data linking product access to claimed educational or economic harms after controlling for socioeconomic confounders.[159] Where period poverty occurs, it correlates strongly with intersecting factors like homelessness or incarceration, underscoring that targeted equity claims risk oversimplifying causal realities rooted in broader economic inequities.[149]

Workplace Accommodations and Biological Realism

Menstruation imposes biological constraints on female productivity due to symptoms such as dysmenorrhea, which affects 45-95% of menstruating women and often leads to reduced focus and performance.[162] Severe cases, reported in 30% of affected women, correlate with absenteeism rates of 13-39% and presenteeism in 64-96% of instances, where individuals attend work but operate at diminished capacity.[163][164] Presenteeism contributes more substantially to overall productivity loss than absenteeism, as symptoms like pain and fatigue persist without full work disruption.[165] These biological effects translate to measurable economic burdens on employers, with annual costs from menstrual disorders estimated at $8.6 billion in the United States, 72% attributable to productivity reductions.[166] In the United Kingdom, absences and impairments from painful periods and related conditions cost £11 billion yearly, while Australia faces $14 billion in losses from similar issues.[167][168] Such data underscore the causal link between female-specific reproductive physiology and workforce inefficiencies, necessitating accommodations grounded in empirical symptom severity rather than generalized equity claims. Workplace accommodations for menstruation typically include paid leave options, flexible scheduling, or access to private facilities, implemented in countries like Japan (since 1947), Indonesia, South Korea, Taiwan, Vietnam, Zambia, and Spain (from 2023).[169][170] These policies limit leave to 1-3 days per cycle, often unpaid or optional, aiming to mitigate acute symptoms without broad disruption.[171] However, uptake remains low; in Japan, women average only 0.9 days of menstrual leave annually, indicating that biological resilience, pain management strategies, or cultural preferences for discretion often suffice without formal invocation.[172] Biological realism demands that accommodations prioritize verifiable causal impacts—such as targeted support for severe dysmenorrhea cases—over universal mandates that risk stigmatizing menstruation as inherent weakness or inflating administrative costs without proportional gains.[173] Evidence of limited policy utilization suggests many women adapt to cyclical impairments through individual means, aligning with historical norms where sex-specific biology was accommodated pragmatically rather than through expansive entitlements.[172] Policies ignoring this variability, or those influenced by advocacy disconnected from uptake data, may exacerbate perceptions of female fragility, potentially deterring hiring in competitive sectors.[174]

Gender and Biological Determinism in Discourse

Biological determinism frames menstruation as a physiological process inextricably linked to female sex, governed by genetic (primarily XX chromosomes), hormonal (estrogen and progesterone cycles), and anatomical factors (ovaries, uterus, and endometrium) that enable the buildup and shedding of uterine lining in the absence of pregnancy.[2] This perspective emphasizes causal mechanisms rooted in reproductive biology, where ovulation triggers endometrial proliferation, and the lack of implantation leads to menstrual flow, a trait evolved in humans and select mammals for efficient pregnancy preparation.[1] Empirical studies confirm these processes occur exclusively in individuals with functional female reproductive tracts, underscoring sex-specific determinism over social or identity-based constructs.[175] In contemporary discourse, particularly within gender studies and advocacy, biological determinism faces challenges from ideologies prioritizing gender identity over sex, prompting shifts to terms like "people who menstruate" or "menstruators" to encompass transgender men and non-binary individuals who retain female anatomy post-transition.[176] This linguistic reframing, evident in campaigns and media since the mid-2010s, seeks inclusivity but has drawn criticism for obscuring the immutable biological prerequisites of menstruation, which cannot manifest in those without ovaries or a uterus, irrespective of self-identified gender.[177] For example, in 2020, author J.K. Rowling questioned the erasure of "women" in such phrasing, arguing it dilutes recognition of sex-based realities amid broader debates on reproductive health policy and single-sex spaces.[177] Proponents of gender-neutral language, often aligned with institutional frameworks in academia and NGOs, contend it mitigates stigma for gender-diverse groups, yet biological evidence remains unaltered: no peer-reviewed data supports menstruation in biological males, even with hormone therapies, as these do not replicate ovarian cyclicity or endometrial response.[178] Critics, including biologists and sex-based rights advocates, highlight how such discourse can complicate clinical research and public health messaging, where precise sex-differentiated data—such as menstrual cycle impacts on vaccine responses or athletic performance—are essential for accuracy.[179][146] This tension reflects broader ideological pressures, where sources favoring inclusivity may underemphasize deterministic biology, potentially at odds with empirical causal chains in reproductive physiology.[180]

Recent Developments in Research

Advances in Menstrual Health Studies (Post-2020)

Post-2020 research has increasingly positioned the menstrual cycle as a vital sign for broader health monitoring, with studies demonstrating its utility in predicting chronic conditions such as cardiovascular disease and diabetes. A 2025 Lancet review emphasized that cycle length irregularities correlate with elevated risks of premature mortality and gynecologic disorders, advocating for routine tracking in clinical practice to enable early intervention.[181] Large-scale longitudinal efforts, including the Apple Women's Health Study launched in 2020 and updated through 2025, have analyzed self-reported data from over 100,000 participants, revealing associations between cycle variability and factors like age, BMI, and hormonal contraceptives, thereby advancing epidemiological insights into cycle dynamics as indicators of systemic health.[182] Empirical investigations into menstrual disruptions following SARS-CoV-2 infection and vaccination have yielded consistent findings of temporary cycle alterations, typically resolving within one to two cycles. A 2024 analysis of unvaccinated participants with COVID-19 reported a mean 1.45-day increase in cycle length compared to pre-event baselines, attributed to inflammatory immune responses affecting hypothalamic-pituitary-ovarian axis function.[183] Similarly, multiple cohort studies, including those from the Apple Women's Health Study, documented heavier bleeding and prolonged cycles post-vaccination in approximately 20-30% of reproductive-age women, with odds ratios for changes ranging from 1.2 to 1.8, though no long-term fertility impacts were observed.[184][185] These effects highlight the menstrual cycle's sensitivity to acute stressors, informing causal models of immune-endocrine interactions without evidence of permanent harm.[186] Advances in endometriosis research have focused on diagnostic precision and targeted therapies, leveraging big data and imaging innovations. A 2025 UCSF study utilized genomic and phenotypic datasets from thousands of patients to identify biomarkers accelerating diagnosis from years to months, addressing historical delays due to symptom overlap with other conditions.[187] Non-surgical options, including immunomodulatory drugs inspired by cancer therapies, showed promise in phase II trials for reducing lesion growth via inhibition of inflammatory checkpoints, with preclinical models confirming efficacy in suppressing ectopic endometrial proliferation.[188] Enhanced MRI techniques and AI-assisted laparoscopy, reported in 2024 reviews, improved detection rates by 40-50% for deep infiltrating lesions, facilitating personalized treatment plans that minimize surgical recurrence.[189] For premenstrual dysphoric disorder (PMDD), neurosteroid modulators have emerged as novel interventions targeting allopregnanolone dysregulation. Phase II trials of sepranolone, administered subcutaneously in the luteal phase, reduced core PMDD symptoms by 25-30% versus placebo, outperforming traditional SSRIs in rapidity of onset due to direct GABA-A receptor agonism.[190] Complementary research on synthetic allopregnanolone analogs demonstrated sustained mood stabilization in luteal-phase dosing, with meta-analyses confirming hormonal therapies' superiority over continuous progestins for symptom relief without exacerbating physical PMS.[191] Internet-delivered cognitive behavioral therapy incorporating emotion regulation, evaluated in 2025 randomized trials, yielded moderate effect sizes (Cohen's d ≈ 0.6) for reducing irritability and anxiety, offering scalable alternatives to pharmacotherapy.[192] Physiological studies have clarified cycle-phase influences on performance and immunity, debunking exaggerated claims while affirming modest effects. A 2025 meta-analysis of cognitive tasks found no significant fluctuations across phases, contradicting prior anecdotal reports and attributing perceived changes to expectancy biases rather than hormonal causality.[193] In contrast, athletic research documented 5-10% variations in strength and endurance during the luteal phase, linked to elevated progesterone's impact on thermoregulation and substrate utilization, with implications for training optimization.[194] Immune profiling revealed cyclic shifts in T-cell activation and cytokine profiles, with follicular-phase advantages in vaccine responses, as evidenced by post-2020 influenza and COVID-19 immunogenicity data.[195] These findings underscore the cycle's role in modulating recovery and stress adaptation, prioritizing empirical measurement over narrative-driven interpretations.[196]

Gaps in Clinical and Epidemiological Data

Despite regulatory changes such as the 1993 FDA guidelines mandating inclusion of women in clinical trials, menstruating individuals continue to be underrepresented in biomedical research, with studies from 1970 to 2019 showing persistent gaps in trial participation, particularly for non-reproductive endpoints.[197][198] This exclusion stems from concerns over menstrual cycle variability confounding results, leading to insufficient data on how pharmaceuticals and interventions interact with hormonal fluctuations, as evidenced by ongoing disparities where women's health conditions like endometriosis receive funding 20-50 times lower relative to disease burden compared to male-dominated equivalents.[199][200] Epidemiological studies on menstrual cycles heavily rely on self-reported data from apps and surveys, introducing recall bias and selection effects, as participants contributing multiple cycles are overrepresented, skewing patterns toward regular users who may differ demographically from the broader population.[201][202] For instance, large cohort analyses reveal cycle length variations by ethnicity—1.6 days longer on average for Asian participants and 0.7 days for Hispanic—but these findings are limited by unverified self-reports and underrepresentation of low-income or non-Western groups, hindering generalizability.[202] Longitudinal data across the reproductive lifespan remains sparse, with most research focusing on ages 18-40, understudying perimenopausal transitions or adolescent irregularities linked to cardiovascular risks.[85][203] Clinical gaps persist in evaluating menstrual technologies and disorders; a 2023 review identified deficiencies in standardized outcome measures for products like cups and tampons, with few randomized trials assessing efficacy, safety, or long-term health impacts beyond basic absorption.[204] Prevalence estimates for conditions such as dysmenorrhea and irregular cycles vary widely (e.g., 27% for irregularity in some cohorts), but diagnostic delays average 7-10 years due to inconsistent epidemiological tracking and underintegration into primary care.[205][206] Emerging factors like air pollution's endocrine-disrupting effects on cycle length show promise in small studies but lack robust, population-level confirmation, underscoring needs for causal analyses over correlational data.[207] Global epidemiological voids are pronounced in low-resource settings, where menstrual health data is neglected in development agendas despite affecting productivity and hygiene access for billions, with only 39% of schools worldwide providing adequate support as of 2024.[208][209] Understudied demographics, including transgender individuals on hormone therapies or ethnic minorities, further limit insights, as highlighted by initiatives like Stanford's 2025 Oura Ring study targeting these groups.[210] Addressing these requires standardized biomarkers, diverse cohorts, and interdisciplinary integration to move beyond historical taboos and funding biases.[211][212]

References

  1. Menstruation: science and society - PMC - PubMed Central
  2. Physiology, Menstrual Cycle - StatPearls - NCBI Bookshelf
  3. Menstrual Cycle Length and Patterns in a Global Cohort of Women ...
  4. Menstrual Cycle (Normal Menstruation): Overview & Phases
  5. The Normal Menstrual Cycle and the Control of Ovulation - NCBI - NIH
  6. Menstruation in Girls and Adolescents: Using the Menstrual Cycle as ...
  7. Study suggests a new explanation for menstruation
  8. The Evolution of Endometrial Cycles and Menstruation
  9. Menstrual Cycle - Women's Health Issues - Merck Manuals
  10. Why do only some animals have periods? - Live Science
  11. The evolution of menstruation: A new model for genetic assimilation
  12. Characteristics of the endometrium in menstruating species
  13. Monkeys, mice and menses: the bloody anomaly of the spiny mouse
  14. How did menstruation evolve? | Max Delbrück Center
  15. Periods and fertility in the menstrual cycle - NHS
  16. Real-world menstrual cycle characteristics of more than ... - NIH
  17. Physiology of the Endometrium and Regulation of Menstruation
  18. The Menstrual Endometrium: From Physiology to Future Treatments
  19. Physiology of the Endometrium and Regulation of Menstruation
  20. Menstrual Bleeding Patterns Among Regularly Menstruating Women
  21. The Duration of Menstrual Blood Loss: Historical to Current ... - MDPI
  22. Menstrual cycle: What's normal, what's not - Mayo Clinic
  23. Menstrual cycle length and modern living: a review - PMC - NIH
  24. how menstrual cycles vary by age, weight, race, and ethnicity
  25. Proteomic Analysis of Menstrual Blood - PMC - NIH
  26. The composition of menstrual fluid, its applications, and recent ...
  27. How Much Blood Do You Lose on Your Period? - Healthline
  28. How much period blood is normal? - Clue app
  29. Innovative Hematology Analysis Using Menstrual Blood
  30. Dysmenorrhea - AAFP
  31. Dysmenorrhea: Background, Pathophysiology, Etiology
  32. Mood symptoms and gut function across the menstrual cycle in ...
  33. Premenstrual syndrome (PMS) - Symptoms & causes - Mayo Clinic
  34. Premenstrual syndrome: new insights into etiology and review of ...
  35. Premenstrual Syndrome and Premenstrual Dysphoric Disorder - AAFP
  36. Variance in Mood Symptoms Across Menstrual Cycles - NIH
  37. Factors associated with regularity and length of menstrual cycle
  38. Factors associated with regularity and length of menstrual cycle
  39. The evolution of endometrial cycles and menstruation - PubMed
  40. [PDF] Energy Economy in the Evolution of Menstruation
  41. The evolution of menstruation: a new model for genetic assimilation
  42. Explainer: why do women menstruate? - The Conversation
  43. The significance and evolution of menstruation - PubMed
  44. Evolution, the Menstrual Cycle, and Theoretical Overreach
  45. Estrous and Menstrual Cycles - Illinois Experts
  46. The Estrous Cycle
  47. MENSTRUA
  48. Comparative histopathology of the estrous or menstrual cycle in ...
  49. Dysmenorrhoea and prostaglandins: pharmacological ... - PubMed
  50. Dysmenorrhea: Menstrual Cramps, Causes & Treatments
  51. Dysmenorrhea: Painful Periods - ACOG
  52. Estimating menstrual blood loss in women with normal ... - PubMed
  53. Female work capacity during the menstrual cycle - PubMed
  54. The prevalence and risk factors of dysmenorrhea - PubMed
  55. Dysmenorrhea - PubMed
  56. Dysmenorrhea and Endometriosis in the Adolescent - ACOG
  57. Causes of menorrhagia - ScienceDirect.com
  58. About Heavy Menstrual Bleeding - CDC
  59. Prevalence of Heavy Menstrual Bleeding and Its Associated Factors ...
  60. Amenorrhea: Practice Essentials, Pathophysiology, Etiology
  61. Amenorrhea - StatPearls - NCBI Bookshelf - NIH
  62. Menstruation Disorders in Adolescents - Medscape Reference
  63. The prevalence, impairment, impact, and burden of premenstrual ...
  64. New data shows prevalence of Premenstrual Dysphoric Disorder
  65. Endometriosis - World Health Organization (WHO)
  66. Endometriosis: Epidemiology, Diagnosis and Clinical Management
  67. The relationship between heavy menstrual bleeding, iron deficiency ...
  68. Thyroid hormones and menstrual cycle function in a longitudinal ...
  69. Role of Thyroid Dysfunction in Patients with Menstrual Disorders in ...
  70. Menorrhagia as main presentation sign of severe hypothyroidism in ...
  71. Treatments for seizures in catamenial (menstrual‐related) epilepsy
  72. Basics about Catamenial Epilepsy
  73. Menstrual Migraines (Hormone Headaches) - Cleveland Clinic
  74. Menstrual Migraine Treatment and Prevention | AMF
  75. Associations of Menstrual Cycle Regularity and Length With ...
  76. Menstrual Cycle Regularity and Length Across the Reproductive ...
  77. Association of heavy menstrual bleeding with cardiovascular ...
  78. Long Menstrual Cycle Is Associated with Type 2 Diabetes Mellitus in ...
  79. Menstrual Cycle Characteristics, Lifestyle Factors, and Risk of Type ...
  80. The Effect of the Menstrual Cycle on Glucose Control in Women With ...
  81. The impact of autoimmune disease on women
  82. Menstruation and Lupus - LupusCorner
  83. Immunology and the menstrual cycle - PubMed
  84. The association between premenstrual dysphoric disorder and ...
  85. PMS & PMDD - MGH Center for Women's Mental Health
  86. Healthy Habits: Menstrual Hygiene - CDC
  87. How Often Should You Change Your Pad? - Healthline
  88. Historical Perspectives Reduced Incidence of Menstrual Toxic ...
  89. Association of characteristics of tampon use with menstrual toxic ...
  90. Menstrual cup and risk of IUD expulsion – a systematic review
  91. Menstrual products: A comparable Life Cycle Assessment
  92. A systematic review and meta-analysis of reusable menstrual pads ...
  93. Environmental impact of menstrual hygiene products - PMC - NIH
  94. Use of Menstrual Sanitary Products in Women of Reproductive Age
  95. General Approaches to Medical Management of Menstrual ... - ACOG
  96. Menstrual suppression: current perspectives - PMC - NIH
  97. Delaying your period with hormonal birth control - Mayo Clinic
  98. What to Know About Skipping Periods With Birth Control - ACOG
  99. Hormonal contraception for menstrual suppression - UpToDate
  100. Highlights of prescribing information: Depo-Provera CI ... - Pfizer
  101. Hormonal IUD (Mirena) - Mayo Clinic
  102. Menstrual Suppression - StatPearls - NCBI Bookshelf - NIH
  103. Hormonal Contraception and Bone Health in Adolescents - Frontiers
  104. Hormonal contraception's effect on adolescent bone health
  105. Estrogen, progestin, and beyond: thrombotic risk and contraceptive ...
  106. New study adds to evidence of stroke and heart attack risk with ...
  107. Progestin-Only Hormonal Birth Control: Pill and Injection - ACOG
  108. Oral Contraceptives and Hypertension Risk: Implications for ...
  109. Perspectives on the side effects of hormonal contraceptives among ...
  110. Promoting Improved Access to Tailored Hormonal Contraceptive ...
  111. 81 THE MENSTRUAL “TABOO” IN ANCIENT EGYPT* I ... - jstor
  112. Did Ancient Egyptians Use Tampons? - Dr. Smiti Nathan
  113. What was it like to get your period in ancient Greece?
  114. Menstrual Blood: Uses, Values, and Controls in Ancient Rome
  115. Cultural aspects and mythologies surrounding menstruation and ...
  116. Getting Your Period in the Middle Ages | Getty News
  117. Feminine Hygiene - Rosalies Medieval Woman
  118. Rituals, Taboos, and Seclusion: Life Stories of Women Navigating ...
  119. Banished for menstruating: the Indian women isolated while they ...
  120. “'Periodical Habits': Native American Women, Movement, and ...
  121. The Great Wall around periods: Beliefs and attitudes ... - Sexgenlab
  122. A Cross‐Cultural Study of Menstruation, Menstrual Taboos, and ...
  123. Socio-cultural implications for women's menstrual health in the ...
  124. Menstrual Taboos: Moving Beyond the Curse - NCBI - NIH
  125. If the body isn't sacred, nothing is: why menstrual taboos matter
  126. How did menstruation become taboo? - Clue app
  127. Women's extreme seclusion during menstruation and children's ...
  128. Women do not synchronize their menstrual cycles - PubMed
  129. Do menstrual cycles sync? Unlikely, finds Clue data
  130. Premenstrual Syndrome - StatPearls - NCBI Bookshelf - NIH
  131. Psychiatric Symptoms Across the Menstrual Cycle in Adult Women
  132. Menstrual blood loss... What's normal?
  133. Very Heavy Menstrual Flow - CeMCOR
  134. Exercise for dysmenorrhoea - PubMed
  135. Current evidence shows no influence of women's menstrual cycle ...
  136. Effects of the menstrual cycle on exercise performance - PubMed
  137. https://www.unicef.org.au/stories/busted-eight-myths-about-periods
  138. Period Poverty and Promoting Menstrual Equity | JAMA Health Forum
  139. Period poverty and its reach across the US | Brookings
  140. Period Poverty: A Neglected Public Health Issue - PMC - NIH
  141. Period Poverty – why millions of girls and women cannot afford their ...
  142. Period poverty: the statistics around the world | ActionAid UK
  143. https://www.aap.org/en/news-room/news-releases-from-aap-conferences/period-poverty-research-finds-1-in-3-teens-lack-access-to-menstruation-products/
  144. Editorial: Period poverty - PMC - NIH
  145. Cost of Having Your Period in Every Country and U.S. State
  146. How Inflation Impacts the Pink Tax and the Period Product Industry
  147. Period poverty in the United States of America: a socio-economic ...
  148. Experiences of menstruation in high income countries: A systematic ...
  149. An observational study assessing the impact of free little period ...
  150. [PDF] Law's Ability to Further the "Menstrual Movement"
  151. Menstrual cycle-associated symptoms and workplace productivity in ...
  152. Effects of dysmenorrhea on work productivity and quality of life in ...
  153. (PDF) Dysmenorrhea among working women and its effect on their ...
  154. Productivity loss due to menstruation-related symptoms
  155. Association between menstrual disorders and women's workforce ...
  156. Women missing work due to painful periods costing UK €13 billion
  157. Problematic periods cost Australians billions each year, research finds
  158. The Pros and Cons of Menstrual Leave Policies in the Workplace
  159. Time Off Work For Menstruation: A Good Idea? by Deborah A. Widiss
  160. [PDF] An Analysis of Menstrual Leave as a Legal Workplace Benefit
  161. Could 'menstrual leave' change the workplace? - BBC
  162. Let's talk about it: The controversy surrounding menstrual leave policy
  163. The controversy behind paid menstrual leave, explained - The Hill
  164. 3 The significance and evolution of menstruation - ScienceDirect.com
  165. Degendering Menstruation: Making Trans Menstruators Matter - NCBI
  166. J.K. Rowling accused of transphobia after mocking 'people who ...
  167. The science behind periods and gender - Clue app
  168. Menstruation Is an Afterthought in Research. Here's ... - Ms. Magazine
  169. Encyclopedia of Gender and Society - Biological Determinism
  170. The menstrual cycle: a vital sign across the lifespan - The Lancet
  171. Study Updates | Apple Women's Health Study
  172. Associations Among Menstrual Cycle Length, Coronavirus... - LWW
  173. COVID-19 vaccines and menstrual cycles | Study Updates
  174. Anti-COVID-19 Vaccination Alters the Menstrual Cycle and Dose ...
  175. Menstrual Changes after COVID-19 Infection and COVID-19 ... - NIH
  176. Big Data Begins to Crack the Case of Endometriosis - UCSF
  177. Immunopathological insights into endometriosis: from research ...
  178. Endometriosis: recent advances that could accelerate diagnosis and ...
  179. Sepranolone: A New Treatment for PMDD?
  180. Allopregnanolone Sparks Interest as New PMDD Treatment
  181. Emotion regulation-based internet-delivered cognitive behavioural ...
  182. Menstrual cycle effects on cognitive performance: A meta-analysis
  183. Effects of menstrual cycle phases on athletic performance and ...
  184. COVID-19 pandemic and the menstrual cycle - Oxford Academic
  185. The impact of menstrual cycle phase and symptoms on sleep ...
  186. Why are women and people with cycles underrepresented in health ...
  187. Why we know so little about women's health - AAMC
  188. Women's health research lacks funding – these charts show how
  189. Shifting Priorities in Women's Health: 6 Trends to Watch in Clinical ...
  190. Challenges and future directions in menstrual cycle research - PMC
  191. Menstrual cycle length variation by demographic characteristics from ...
  192. Chronicling menstrual cycle patterns across the reproductive ...
  193. OHSU study finds significant gaps in menstrual research and clinical ...
  194. Prevalence of menstrual problems and their association with ... - NIH
  195. Real-World Evidence Shows Gaps in Awareness, Medical Help ...
  196. The effect of air pollution exposure on menstrual cycle health using ...
  197. Global report reveals major gaps in menstrual health and hygiene in ...
  198. Global Health Priorities and the Neglect of Menstrual Health and ...
  199. Oura Ring to be Used in New Study on Menstrual Research Across ...
  200. Research priorities for improving menstrual health across the life ...
  201. Overview of Research Gaps for Selected Conditions in Women's ...
  202. Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea
  203. Dysmenorrhea: Painful Periods
  204. Mayo Clinic: Menstrual cycle
  205. NCBI Bookshelf: Heavy Periods
  206. ACOG: Menstruation in Girls and Adolescents
  207. Period Blood Color Chart: Black, Brown, Bright Red, and More
  208. Period Blood Clots: Should You Be Concerned?
  209. Blood clots during menstruation: A concern?
  210. Exercise During Period: What You Should Do and Avoid
  211. Physical activity and your menstrual cycle
  212. Brown Spotting Before Period: Ovulation, Pregnancy, Other Causes
  213. Brown Discharge: 4 Causes and What It Means
  214. Menstrual cycle: What's normal, what's not - Mayo Clinic
  215. Mittelschmerz - Symptoms and causes - Mayo Clinic
  216. Am I Pregnant? Early Symptoms of Pregnancy & When To Test
User Avatar
No comments yet.